Gregory J. Nadolski, M.D.
Associate Professor of Radiology at the Hospital of the University of Pennsylvania
Co-Director, Penn Image Guided Interventions (PIGI) Laboratory
Active Radiologist, Pennsylvania Hospital
Active Radiologist, Penn Presbyterian Medical Center
Attending Radiologist, Hospital of the University of Pennsylvania
Active Medical Staff, Chester County Hospital
IR Research Oversight Committee Member, University of Pennsylvania
Member IR/DR Residency Selection Committee, University of Pennsylvania
IR Representative Center for Surgical Health, University of Pennsylvania
Department: Radiology
Contact information
Hospital of the University of Pennsylvania
Department of Radiology
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Department of Radiology
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104
Office: 215.662.7892
Fax: 215.615.3545
Fax: 215.615.3545
Education:
B.S. (Biochemistry)
University of Wisconsin, Madison, WI , 2001.
M.D. (Medicine)
Indiana University School of Medicine, Indianapolis, IN , 2007.
MS (Translational Research)
University of Pennsylvania, Philadelphia, PA, 2017.
Permanent linkB.S. (Biochemistry)
University of Wisconsin, Madison, WI , 2001.
M.D. (Medicine)
Indiana University School of Medicine, Indianapolis, IN , 2007.
MS (Translational Research)
University of Pennsylvania, Philadelphia, PA, 2017.
Description of Clinical Expertise
My research and clinical interests include multimodality therapies for the treatment of hepatocellular carcinoma and liver dominant metastatic cancer.I have initiated or participated in multiple clinical trials at the Hospital of the University of Pennsylvania for treating hepatocellular carcinoma and metastatic cancers to the liver. Several of these trials are multi-modality treatments in collaboration with other medical subspecialties.
My other area of clinical and research interest is lymphatic injury, dysfunction, and malformations. Clinically, I perform thoracic duct embolization to treat chylothorax. I participate in research investigating novel lymphatic interventions to treat chylothorax, chylous ascites, refractory ascites and protein losing enteropathy.
Description of Research Expertise
My clinical and research expertise center on lymphatic interventions and multimodality cancer therapies to treat primary and secondary liver tumors. I also conduct research on diseases of the liver such as treatment of portal hypertension and ascites.Selected Publications
Hung ML, Jairam A, Carr M, Berman ZT, Taddonio M, Minocha J, Aryafar H, Mondschein JI, Soulen MC, Nadolski GJ, Redmond J. : Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound vs fluoroscopic guidance: A dual-institution retrospective comparative study. World Journal of Hepatology 17(5), May 2025.Moon HE, Hur S, Moon J, Lee SH, Choi H, Ratnam L, Nadolski G, Itkin M.: Lymphatic Embolization for Primary Genital Lymphorrhea and Chylous Reflux-Related Lower Limb Lymphedema. JVIR 36(5), May 2025.
Cornman-Homonoff J, Fortune BE, Kolli KP, Kothary N, Nadolski G, Thornburg BG, Verma S, Madoff DC: Management of Ascites: AJR Expert Panel Narrative Review. AJR Am J Roentgenology April 2025 Notes: epub ahead of print.
Gurevich A, Islam A, Wakim J, Yarsky E, Kiefer R, El-Ghazal R, McClung G, Cormode DP, Nadolski GJ, Avritscher R, Hunt SJ, Gade TPF: Comparison of Liquid with Particle Embolics in a Translational Rat Model of Hepatocellular Carcinoma: Histologic and Radiographic Responses. JVIR 36(4), April 2025.
K. Rao,S. Kayfan,R. Romano,...G. Nadolski, R. Cobb,S. Hunt,M. Soulen: Premedication with NK-1 Antagonists and COX-2 Inhibitors Improves Same-Day Discharge Rates Following Chemoembolization for Hepatocellular Carcinoma and Neuroendocrine Liver Metastasis. JVIR 36(3S): S109-110, March 2025.
S. Bhatte,A. Cun,C. DeSanto,...G. Nadolski,S. Hunt,D. DePietro: Drain for Life? Outcomes of Percutaneous Drainage of Malignancy-Associated Abscesses. JVIR 36(3S): S204-5, March 2025.
R. Savoor,S. Hunt,T. Gade,...E. Ben-Josef,M. Soulen,G. Nadolski: Pilot Randomized Trial of Transarterial Chemoembolization with or without Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients Awaiting Transplantation. JVIR 36(3S): S109, March 2025.
J. Wolff,C. Jackson,M. Machristie,...T. Gibson,G. Nadolski,R. Shlansky-Goldberg: FEATURED ABSTRACT The Effects of a Standardized Enhanced Recovery After Surgery (ERAS) Pain Management Protocol for Patients Undergoing a Uterine Fibroid Embolization (UFE). JVIR 36(3S): S115, March 2025.
T. Fu,J. Lundberg, R. Cobb, G. Nadolski, T. Gade,S. Hunt: A Single Institutional Experience with Pulsed Electric Field Ablation in the Treatment of Patients with Localized and Metastatic Cancer. JVIR 36(3S): S100-101, March 2025.
J. Kus,G. Nadolski,S. Hunt,...S. Shamimi-Noori,M. Soulen,D. DePietro: Utility of Alpha-Fetoprotein (AFP) Monitoring After Y-90 Radioembolization of Hepatocellular Carcinoma in Non-AFP Producers. JVIR 36(3S): S199-200, March 2025.